SIGA to Host Business Update Call on March 10, 2026, Following Release of 2025 Financial Results
Rhea-AI Summary
SIGA (Nasdaq: SIGA) will host a business update webcast and conference call on March 10, 2026 at 4:30 P.M. ET. Management participants include CEO Diem Nguyen and CFO Daniel Luckshire. The live webcast and an archived replay will be available via the company's Investor Relations website. Dial‑in numbers and a two‑week replay access with Conference ID 1122478 are provided for domestic and international callers.
Positive
- None.
Negative
- None.
News Market Reaction – SIGA
On the day this news was published, SIGA declined 5.04%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Sector peers showed mixed moves, with ESPR flagged on momentum scanners and down ~5.2%, while others like AQST and EBS moved higher, suggesting stock-specific drivers rather than a unified sector trend.
Previous Earnings Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Nov 06 | Q3 2025 earnings | Positive | -19.9% | Strong nine‑month revenues and income plus Japan approval and special dividend. |
| Aug 05 | Q2 2025 earnings | Positive | +10.0% | Strong Q2 product sales, BARDA funding and sharply higher net income. |
| May 08 | Q1 2025 earnings | Neutral | +4.0% | Lower quarterly revenue but sizeable orders, Japan approval and dividend. |
| Mar 11 | FY 2024 earnings | Positive | +7.0% | Strong 2024 product sales, high pre‑tax income and broad international demand. |
| Nov 07 | Q3 2024 earnings | Positive | -0.8% | Large new orders and solid revenues with growing procurement backlog. |
Earnings-related releases have often been positive fundamentally, but price reactions have been mixed, with both strong rallies and sharp sell-offs following recent financial updates.
Over the past five earnings-related releases from Nov 2024 through Nov 2025, SIGA reported growing product sales, significant BARDA-related funding, and multiple international approvals for TPOXX/TEPOXX. Several updates highlighted large procurement orders, special cash dividends, and strong net income in 2024–2025. However, at least one quarter showed weaker revenue due to delivery timing and produced a notable share-price decline. Today’s call announcement precedes full-year 2025 results and fits into this pattern of frequent, detailed financial communication.
Historical Comparison
Recent earnings updates have paired sizeable TPOXX orders and international approvals with mixed share reactions. This pre-announcement call fits the same earnings cycle but precedes actual financial metrics.
Earnings releases progressed from strong Q3 2024 orders through solid 2024 full-year results and increasingly large 2025 product sales and BARDA funding, leading into the upcoming 2025 full-year report.
Market Pulse Summary
The stock moved -5.0% in the session following this news. A negative reaction despite this routine call announcement would fit a history where some fundamentally solid earnings reports were followed by sell-offs. Earlier periods showed that timing of product deliveries and quarterly lumpiness could weigh on sentiment even when annual figures looked strong. In such cases, investors usually focused on order backlog details, funding updates and international demand trends to reassess the longer-term picture.
AI-generated analysis. Not financial advice.
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, March 10, 2026. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer.
A live webcast of the call will also be available on the Company's website at http://www.siga.com in the Investor Relations section of the site, or by clicking here. Please log in approximately 5-10 minutes prior to the scheduled start time.
Participants may access the call by dialing 1-800-717-1738 for domestic callers or 1-646-307-1865 for international callers.
A replay of the call will be available for two weeks by dialing 1-844-512-2921 for domestic callers or 1-412-317-6671 for international callers and using Conference ID: 1122478. The archived webcast will be available in the Investor Relations section of the Company's website.
About SIGA
SIGA is a commercial-stage pharmaceutical company and leader in global health focused on the development of innovative medicines to treat and prevent infectious diseases. With a primary focus on orthopoxviruses, we are dedicated to protecting humanity against the world’s most severe infectious diseases, including those that occur naturally, accidentally, or intentionally. Through partnerships with governments and public health agencies, we work to build a healthier and safer world by providing essential countermeasures against these global health threats. For more information about SIGA, visit www.siga.com.
Contact:
Suzanne Harnett
sharnett@siga.com
FAQ
When will SIGA (SIGA) host its business update call and who will speak?
How can investors access the live SIGA (SIGA) webcast and conference call on March 10, 2026?
Will there be a replay of the SIGA (SIGA) March 10, 2026 business update call and how long is it available?
Where will the archived webcast of SIGA's (SIGA) March 10, 2026 call be posted?
What should participants do before joining SIGA's (SIGA) March 10, 2026 webcast and call?
